Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Adrenal Disorders
Would you recommend testing for adrenal dysfunction in a euvolemic and hypertensive patient on anti-hypertensive therapy presenting with combined hyperkalemia and hyponatremia?
Related Questions
Should we be using a cut off of 20 rather than the traditional 10 Hounsfield units to distinguish between benign and malignant adrenocortical tumors on imaging?
Do progesterone only oral contraceptive pills affect cortisol binding globulin?
How do you approach monitoring for autoimmune disorders in patients with surgical remission of Cushing’s disease, given the higher incidence of autoimmune disease in this population?
How does contralateral suppression of more than 50% with cosyntropin during adrenal venous sampling influence your decision to recommend adrenalectomy in patients with primary aldosteronism?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
What evaluation do you do in patients with hypertension and persistently elevated aldosterone/renin ratio (over 20) but without an elevated aldosterone level (under 10 ng/dL)?
What factors guide you in adjusting the dose of fludrocortisone in a patient with primary adrenal insufficiency?
Is adequate BP control sufficient enough when titrating spironolactone therapy for primary hyperaldosteronism treatment?
Under what circumstances would you test for hypercortisolism in a patient with insulin resistance?
Do you recommend combined baseline cortisol and DHEA-S testing to improve the efficiency and accuracy of adrenal insufficiency diagnosis?
